Joint action of miR‐126 and MAPK/PI3K inhibitors against metastatic melanoma

Emerging data support the rationale of combined therapies in advanced melanoma. Specifically, the combined use of drugs with different mechanisms of action can reduce the probability of selecting resistant clones. To identify agents active against melanoma cells, we screened a library of 349 anti‐ca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Pedini, Francesca, De Luca, Gabriele, Felicetti, Federica, Puglisi, Rossella, Boe, Alessandra, Arasi, Maria Beatrice, Fratini, Federica, Mattia, Gianfranco, Spada, Massimo, Caporali, Simona, Biffoni, Mauro, Giuliani, Alessandro, Carè, Alessandra, Felli, Nadia
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717748/
https://ncbi.nlm.nih.gov/pubmed/31115969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12506
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados